BioView Presents Promising Results from Their Joint Liquid Biopsy Development Project

BioView Ltd. (TASE: BIOV), a company developing advanced medical imaging systems for cancer cell detection, traded on the Tel Aviv Stock Exchange, today announced the completion of the first stage of its joint project with a partner from the UK. The companies presented results from their collaborative liquid biopsy development effort at the prestigious AACR International Liquid Biopsy Conference.